What are the Top 7 Trends in the US Anesthesia, Respiratory, and Sleep (ARS) Device Market?
The U.S. anesthesia, respiratory, and sleep (ARS) device market reached nearly $7 billion in 2024 and is forecast to approach $9 billion over the next several years.
While global inflation cooled after the 2021–2022 spike, ARS suppliers benefited from steadier pricing and resilient demand, setting the stage for consistent expansion.
Competitors are now facing both pressure and opportunity as hospitals and homecare markets seek safer, more efficient, and more connected technologies.
Find growth niches in minutes, not months.
Explore quick, actionable insights from the select markets.
Table of Contents
➜ What Is Driving Growth in the US ARS Device Market?
➜ Are Closed-Loop Anesthesia Systems Common in Operating Rooms?
➜ Are Wireless Anesthesia Monitors Growing in Demand?
➜ How Are AI and Smart Features Changing Ventilators and Oxygen Therapy?
➜ What New Devices Are Used for Sleep Apnea Diagnosis and Treatment?
➜ How Can Companies Use These ARS Market Insights?
Key Takeaways
- The US ARS market is on track to grow from $7B in 2024 to nearly $9B, driven by steady demand and tech adoption.
- Closed-loop anesthesia delivery and eco-friendly systems are expanding in both advanced and resource-limited settings.
- Wireless monitoring, AI-driven ventilators, and portable oxygen therapy are fueling cross-segment growth.
- Sleep therapy and diagnostics are moving toward connected, home-based solutions with rising adoption in primary care.
What Is Driving Growth in the US ARS Device Market?
The ARS market continues to expand steadily thanks to stable pricing and strong procedure demand.
Hospitals are seeking advanced anesthesia delivery systems that reduce waste and improve safety, while payors push for cost efficiency in respiratory and sleep care.
Competitors face rising pressure to offer connected devices as clinicians expect real-time monitoring and remote data integration.
Meanwhile, the expansion of homecare services, particularly for COPD and sleep apnea, presents growth opportunities for portable and patient-friendly solutions.
This shift is forcing manufacturers to balance advanced innovation with accessibility and affordability.
Are Closed-Loop Anesthesia Systems Common in Operating Rooms?
- Growing adoption of eco-friendly, low-flow systems reducing anesthetic gas waste.
- Hospitals increasingly investing in automation to enhance both safety and sustainability.
- 2023: MIT & MGH demonstrated a closed-loop IV anesthesia system that adjusted propofol dosing based on brain state.
Modern anesthesia delivery units now feature closed-loop vaporization and feedback control, improving accuracy and reducing anesthetic gas waste.
In 2023, MIT and Massachusetts General Hospital advanced this trend by demonstrating a closed-loop system that monitored brain state to automatically adjust propofol dosing.
This expansion beyond gas delivery into AI-driven intravenous anesthesia highlights the growing role of precision automation in surgical care.
Hospitals adopting these systems are not only meeting safety goals but also aligning with the industry’s sustainability push.
Competitors investing in precision and sustainability stand to strengthen their positioning as environmental standards gain traction.
Are Wireless Anesthesia Monitors Growing in Demand?
Anesthesia monitors are evolving beyond standard vital signs, now integrating EEG and hemodynamic tracking to personalize anesthesia delivery.
Wireless connectivity and compact designs are making these monitors more versatile across inpatient and outpatient settings. This portability appeals to smaller surgical centers and mobile health units, where demand is rising for cost-effective yet comprehensive monitoring.
Competitors who lag in connectivity features risk losing ground as clinicians increasingly prefer integrated systems.
How Are AI and Smart Features Changing Ventilators and Oxygen Therapy?
Ventilators are advancing with AI-driven adjustment modes and remote monitoring, improving both ICU care and long-term respiratory management.
Portable oxygen concentrators with smart delivery features are also expanding patient access to therapy outside the hospital. COPD prevalence and pandemic preparedness continue to drive demand, particularly in homecare and emerging markets.
Suppliers who can balance affordability with advanced features are well positioned to capture growth across both premium and value segments.
What New Devices Are Used for Sleep Apnea Diagnosis and Treatment?
- Auto-adjusting CPAP/APAP systems improving patient comfort and adherence.
- Shift toward home sleep testing (HST) and wearable diagnostics for broader access.
- 2024: Philips barred from selling new U.S. respiratory devices under an FDA/DOJ consent decree, highlighting regulatory risk
Obstructive sleep apnea therapy devices now include auto-adjusting CPAP/APAP systems with wireless data transmission, improving adherence and enabling remote clinician oversight.
At the same time, diagnostic solutions are shifting toward home sleep testing (HST) and wearable sensors, supported by AI-based scoring tools.
These approaches lower barriers to diagnosis and treatment, creating opportunities in both specialized sleep labs and primary care networks.
As a side note, in 2024, Philips was prohibited from selling new respiratory care devices in the U.S. under a consent decree with the FDA and DOJ, tied to past recalls of sleep therapy products. This event highlights how regulatory scrutiny and product quality directly influence market competition and adoption in the sleep and respiratory space.
Competitors investing in user-friendly, connected sleep solutions are capturing market share as awareness of untreated sleep apnea grows.
How Can Companies Use These ARS Market Insights?
Suppliers should prioritize product portfolios that emphasize connectivity, sustainability, and patient-friendly design.
Aligning anesthesia systems with environmental initiatives can strengthen hospital partnerships, while expanding portable respiratory and sleep solutions will meet rising demand in homecare.
Strategic investments in AI and cloud-based platforms can also support broader adoption by integrating seamlessly with hospital IT systems.
Companies that anticipate the shift toward decentralized and data-driven care will be better positioned to maintain growth.
Conclusion
The U.S. ARS device market is entering a steady growth phase, driven by surgical demand, homecare expansion, and digital health adoption.
Competitors that align with trends in closed-loop anesthesia, wireless monitoring, AI-driven respiratory care, and connected sleep solutions will capture the strongest opportunities.
The U.S. Anesthesia, Respiratory, and Sleep Management Device Market Report provides detailed competitor shares, procedure forecasts, and growth trends you can act on.
Turn market painpoints into opportunities
Explore how procedure trends and competitor positioning create clear openings for industry experts in the market.
